Communicating with patients

December 5, 2005
Sales and Marketing

Despite little prospect of the restrictions in Europe on communicating directly with consumers being relaxed, the issue of DTC communications …

New UK headquarters for Bristol-Myers Squibb

December 5, 2005
Sales and Marketing BMS, UK

Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …

Merck plans diabetes compliance campaign

December 5, 2005
Medical Communications

Merck Pharmaceuticals has engaged Medicom to improve compliance in diabetic patients as part of the communications strategy for its type …

Sanofi-Aventis throws its weight behind Acomplia

December 5, 2005
Sales and Marketing

Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …

Scheuble quits as Merck KGaA chief

December 5, 2005
Sales and Marketing

Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …

58,000 people living with HIV in the UK

December 5, 2005

The number of people living with HIV in the UK is now more than 58,000 – including nearly 20,000 who …

GlaxoSmithKline’s lapatinib hailed as latest ‘wonder drug’

December 1, 2005
Sales and Marketing

GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …

Altana and Serono seeking mergers

November 30, 2005
Sales and Marketing

Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …

Pfizer critical of generic plan for three million statin patients

November 30, 2005

More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …

Pfizer’s new anti-smoking drug shows promise

November 29, 2005
Sales and Marketing

Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …

Pharma unprepared for shift to secondary care

November 28, 2005
Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …

AstraZeneca fights generic Nexium bid

November 25, 2005
Sales and Marketing

AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …

Which company has the industry’s best R&D pipeline?

November 25, 2005
Sales and Marketing

Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …

Chiron to make up shortfall in UK flu vaccine

November 25, 2005
Manufacturing and Production

Chiron has agreed to help the UK government make up a shortfall in flu vaccine supplies by producing an extra …

PR as important as salesforces, say marketers

November 24, 2005
Medical Communications

A new survey of the UK pharmaceutical industry has found PR is considered just as important to marketing efforts as …

FDA clears Tamiflu in children after safety scare

November 22, 2005
Sales and Marketing

The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …

Amgen sues Roche over new anaemia treatment

November 22, 2005
Sales and Marketing

Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …

New antibody could be COPD breakthrough, say companies

November 21, 2005
Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …

Asthma drug warning hits GlaxoSmithKline

November 21, 2005
Sales and Marketing

Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …

Oxford and GSK to collaborate on cancer research in India

November 18, 2005
Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …

The Gateway to Local Adoption Series

Latest content